George Elvira has over fifteen years of experience in the field of Intellectual property (IP). His practice involves most aspects of patent-related work with an emphasis on prosecution, client counselling, and patent portfolio growth and utilization.
With a deep science background, George counsels clients in the context of assessing, improving and implementing an IP strategy in support of their business objectives and corporate strategy. He analyzes and studies competitor products and patent portfolios to identify potential infringement risks and advises clients during the product design process on design-around options and provides advice from the perspective of patent portfolio enforcement and/or licensing opportunities. He regularly coordinates the preparation of market clearance, validity and patentability opinions.
George also works closely with the firm’s transactional team in representing clients in due-diligence investigations on both the buy and sell sides of IP-related transactions and financing, and conducts analysis to assess the strength of a patent portfolio and potential patent infringement risks during investment, technology acquisition or business sale transactions. George also provides technical support to the firm's litigation team.
George advises companies ranging in size from small and medium enterprises to multinational corporations in several industries, including clean tech / energy, industrial, transportation, pharmaceutical / animal health and advanced materials.
- Industry Involvement
- In the Media
- “IP Management: a key prescription for drug discovery,” (co-presenter: Julien Verneau) presentation at BioConnect Symposium, November 2016
- "Bridging the gap between industry and academia," BioConnect 2011, Montreal, November 2011
- Associate, Intellectual Property Institute of Canada; member of the Biotechnology Patents Committee
- Member, BIOQuebec
- "Intellectual Property Rights: a Key Asset for Early Stage Biotechnology Companies" (co-author: Andréanne Auger), The Lawyers Weekly Magazine, February 2008